A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal
|
|||||
|
       
  |
 Comments are closed  Finance  biomedical, cancer, equity, Europe, investment, life sciences, merger, pharmaceuticals, U.K. 
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, genomics, HIV, investment, licensing, life sciences, mathematics, pharmaceuticals, preclinical 
A venture capital company investing in life science and health care businesses raised $1.85 billion to finance biotechnology start-ups. . . . → Read More: Investors Raise $1.85B for Biotech Start-Ups One comment - (Comments are closed) Finance biomedical, biotechnology, Covid-19, entrepreneurs, equity, investment, life sciences, manufacturing, medical device, pharmaceuticals, venture capital 
A biotechnology company designing proteins in food products and therapies for people with food allergies is raising $40 million in its second venture round. . . . → Read More: Food Allergy Biotech Raises $40M in New Funds Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, Israel, life sciences, mathematics, pharmaceuticals, university, venture capital 
A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its second venture funding round. . . . → Read More: Crispr Heart Disease Biotech Raises $94M in New Funds Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, heart disease, investment, licensing, life sciences, pharmaceuticals, university 
Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020. . . . → Read More: 2020 Venture Funds Mixed, Biotech Keeps Sizzling One comment - (Comments are closed) Finance biotechnology, economics, equity, investment, IPO, merger, software, venture capital 
A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, economics, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, venture capital 
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round. . . . → Read More: Synthetic Biology Company Raises $105M in New Funds One comment - (Comments are closed) Finance biomedical, biotechnology, cancer, engineering, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, venture capital 
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute. . . . → Read More: Synthetic Virus Company Forms, Raises $77M 2 comments - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, investment, life sciences, pharmaceuticals, preclinical, venture capital 
The Nasdaq Biotechnology Index, an indicator of investor interest in the industry, rose in December to close up by 26 percent for the year. . . . → Read More: Infographic – Late Charge Boosts Biotech Index |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||